C21 Investments Inc. balance sheet CWLXF

Annual Quarterly

As of Mar 31, 2026, C21 Investments Inc. had total assets of $54.4 million and total liabilities of $29.0 million. Total assets were down 4.5% from a year earlier. Stockholders' equity was $25.4 million. It held $2.2 million in cash and investments against $9.8 million of total debt, net debt of $7.5 million. The current ratio, current assets divided by current liabilities, was 1.30.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
FY 2024
Jan 31, 2024
FY 2023
Jan 31, 2023
FY 2022
Jan 31, 2022
FY 2022
Jan 31, 2021
FY 2020
Jan 31, 2020
FY 2019
Jan 31, 2019
Assets
Cash
2
-14.9%
3
+9.0%
3
+72.4%
2
+27.3%
2
-69.7%
3
6
3
-66.1%
9
Cash and investments
2
-14.9%
3
+9.0%
3
+72.4%
2
+27.3%
2
-69.7%
3
6
3
-66.1%
9
Receivables
0
-54.3%
0
-34.0%
0
-40.7%
0
-52.9%
0
+102.3%
0
—
—
—
Inventory
5
+13.3%
4
+49.6%
3
-31.3%
3
-35.1%
4
+2.9%
4
—
—
—
Total current assets
8
+10.7%
8
+3.6%
8
-5.4%
7
-15.8%
9
-16.4%
10
—
—
—
Property and equipment, net
2
-13.7%
3
-22.4%
3
-27.6%
3
-26.7%
5
-3.8%
5
—
—
—
Goodwill
29
+0.0%
29
+0.0%
29
+0.0%
29
+0.0%
29
+0.0%
29
29
29
-2.4%
29
Total assets
54
-4.5%
57
+4.5%
55
-5.3%
55
-6.5%
58
-12.7%
62
67
61
-20.6%
77
Liabilities and equity
Accounts payable
1
+28.5%
1
-11.7%
1
-20.9%
1
-35.5%
2
+31.3%
1
—
—
—
Total current liabilities
6
-19.7%
8
-43.8%
15
+0.5%
14
-5.4%
15
-6.3%
16
—
—
—
Total liabilities
29
+2.3%
28
+20.6%
24
+1.1%
23
-2.1%
24
-44.9%
28
44
48
-15.0%
56
Stockholders' equity
25
-11.3%
29
-7.6%
31
-9.7%
31
-9.5%
34
+1.7%
34
—
—
—
Debt
Debt due within a year
—
—
—
—
—
—
0
0
—
Long-term debt
—
—
—
—
—
—
0
0
—
Lease liabilities
10
-5.2%
10
+7.7%
10
+6.2%
10
+6.9%
9
-3.5%
9
10
5
-36.8%
8
Total debt
10
-5.2%
10
+7.7%
10
+6.2%
10
+6.9%
9
-9.6%
9
11
6
-27.3%
8
Net cash
-8
+1.8%
-8
-7.2%
-6
+11.5%
-7
-1.4%
-7
-92.6%
-6
-5
-3
-330.5%
1
Ratios
Current ratio
1.30x
0.94x
0.54x
0.51x
0.57x
0.64x
—
—
—
Debt to equity
0.38x
0.36x
0.31x
0.31x
0.26x
0.28x
—
—
—
Debt to EBITDA
2.41x
3.45x
3.30x
3.32x
1.54x
0.80x
0.93x
—
—
Return on equity
-12.75%
-13.84%
-10.67%
-10.65%
0.85%
29.51%
—
—
—
Return on assets
-5.96%
-6.96%
-5.99%
-6.06%
0.50%
16.10%
14.90%
—
—
Book value per share
0.22
0.24
0.26
0.26
0.29
0.28
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
CWLXF (OTC)
Fiscal year ends
March 31
Incorporated in
British Columbia, Canada
Headquarters
Vancouver
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
831609
Former names
CURLEW LAKE RESOURCES INC (until Nov 29, 2012); CURLEW LAKE RESOURCES INC /FI (until Jan 3, 2007)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.